Cyproheptadine Hydrochloride Tablet
Product Images NDC 0115-1757

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 0115-1757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cyproheptadine Hydrochloride Tablets 1)

FDA Label Image

1 (Cyproheptadine Hydrochloride Tablets 2)

1 (Cyproheptadine  Hydrochloride Tablets 2)
This is a description of a medication containing Cyproheptadine hydrochloride, USP 4mg per tablet. It is advised to be stored at a temperature between 20-25°C (68-77°F) and dispensed in a tightly closed container as defined by USP. The tablets are manufactured and distributed by Amneal Pharmaceuticals LLC in Ahmedabad, India, and Bridgewater, NJ, respectively. It is recommended to use a child-resistant closure and keep the medication out of reach of children. The product's Mifg. Lic. No. is 6/25/2137.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.